May 8, 2026 07:00AM
Apr 17, 2026 04:50PM
Apr 17, 2026 04:49PM
Mar 9, 2026 07:00AM
Jan 20, 2026 07:01AM
Jan 20, 2026 07:00AM
Nov 5, 2025 07:00AM Boundless Bio Reports Third Quarter 2025 Financial Results and Business Highlights
May 23, 2025 04:01PM
May 9, 2025 07:00AM
Mar 27, 2025 07:00AM
Aug 12, 2024 04:03PM
Aug 12, 2024 04:01PM
Mar 23, 2023 10:19AM
Dec 3, 2019 09:16AM Pre-Open 12/03: (BOLD) (VRAY) (ALDX) Higher (CBL) (CARA) (CLF) Lower (more...)
Dec 2, 2019 06:29PM
Nov 7, 2019 04:01PM
Oct 7, 2019 07:20AM
Oct 5, 2019 07:01AM
Sep 30, 2019 08:00AM
Aug 6, 2019 04:53PM
Aug 6, 2019 04:01PM Audentes Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update
May 7, 2019 04:01PM
May 1, 2019 02:16PM
May 1, 2019 02:15PM
Apr 15, 2019 04:01PM
Mar 29, 2019 08:55AM
Mar 27, 2019 09:00AM
Feb 27, 2019 04:01PM Audentes Therapeutics Reports Fourth Quarter 2018 and Full Year Financial Results and Provides Corporate Update
Feb 25, 2019 09:25AM
Feb 24, 2019 09:23PM
Jan 31, 2019 08:00AM
Jan 7, 2019 08:00AM
Nov 6, 2018 04:01PM
Oct 5, 2018 08:03AM
Oct 5, 2018 08:01AM Audentes Therapeutics to Provide Update on New Positive Interim Data from ASPIRO, the Phase 1/2 Clinical Trial of AT132 in Patients with X-linked Myotubular Myopathy, from the 23rd International Annua
Oct 5, 2018 08:00AM
Sep 24, 2018 08:05AM
Sep 24, 2018 08:00AM
Aug 22, 2018 06:34AM
Aug 21, 2018 08:01AM
Aug 21, 2018 08:00AM
Aug 7, 2018 06:23AM Audentes Therapeutics (BOLD) Announces Update on ASPIRO Phase 1/2 Clinical Trial of AT132 in Patients with X-Linked Myotubular Myopathy
Aug 7, 2018 06:00AM
Jul 31, 2018 08:00AM
Jun 5, 2018 08:00AM
May 16, 2018 11:30AM
May 16, 2018 11:30AM
May 9, 2018 04:01PM
Apr 30, 2018 01:14PM Audentes Therapeutics Announces Presentation of Data at the 21st Annual Meeting of the American Society of Gene and Cell Therapy
Mar 8, 2018 04:01PM

323,592 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All